Dr. Prof. Bertil Blok, MD, PhD
Claim this profileErasmus Medical Center
More about Prof. Bertil Blok, MD, PhD
Clinical Trial Related
2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Prof. Bertil Blok, MD, PhD has experience with
- Axonics SNM System
Breakdown of trials Prof. Bertil Blok, MD, PhD has run
Fecal Incontinence
Urge Incontinence
Overactive Bladder
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Prof. Bertil Blok, MD, PhD specialize in?
Prof. Bertil Blok, MD, PhD focuses on Fecal Incontinence and Urge Incontinence. In particular, much of their work with Fecal Incontinence has involved treating patients, or patients who are undergoing treatment.
Is Prof. Bertil Blok, MD, PhD currently recruiting for clinical trials?
No, Prof. Bertil Blok, MD, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Prof. Bertil Blok, MD, PhD has studied deeply?
Yes, Prof. Bertil Blok, MD, PhD has studied treatments such as Axonics SNM System.
What is the best way to schedule an appointment with Prof. Bertil Blok, MD, PhD?
Apply for one of the trials that Prof. Bertil Blok, MD, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.